Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
about
Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in AsthmaMolecular Regulation of Toll-like Receptors in Asthma and COPDPositioning new pharmacotherapies for COPDNew combination treatments in the management of asthma: focus on fluticasone/vilanterolCan the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.Advances in targeting cyclic nucleotide phosphodiesterasesClinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma.Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPDIdentification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.Discovery of a highly potent glucocorticoid for asthma treatmentGaining the Upper Hand on Pulmonary Drug Delivery.Focusing the mechanism of action to dissect the different treatments of respiratory allergy.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.β2 AgonistsAdvances in the treatment of virus-induced asthma.The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent mannerProteomic analysis of sputum reveals novel biomarkers for various presentations of asthma.Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model.Budesonide/salmeterol in fixed-dose combination for the treatment of asthma.Combination Therapy with Budesonide and Salmeterol in Experimental Allergic Inflammation.The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma
P2860
Q26747627-55D34EA8-957A-4926-A6AF-F88EE7DB3CA8Q26776173-BD8A4A51-2039-4AF9-8FCD-0D0A773875BBQ26798659-413E6982-FFD3-463E-987D-9875BF526502Q26852898-E0B17871-7C23-4239-A6C7-B358CAF47D06Q28391808-C0CF7262-8EAB-4645-B457-7EF125D4ADA2Q33646667-AB0DC9E6-E9FE-4C36-9A7D-339D85330569Q34139490-0D3B5CB9-4E4C-4521-9B51-B00EAC3857A6Q34338085-2CAE646F-4400-4920-B72C-BE35A0817D0DQ35492192-1E895596-CA9D-4EBE-BF8D-7084A499DD79Q36581576-BAC3A101-A73F-4E19-B799-A5FBBC92435EQ36769629-BEDBA20A-40E7-42CF-BB94-9A6812C71178Q38240156-4AA4AFCD-DF4F-474C-AE12-61EF8E79257EQ38542919-DE0A4197-AFFB-4847-9DB3-4DA373E4785BQ38707759-153F772C-11E2-43D2-B580-91CA8A802A98Q38759118-6A2DAB26-C265-45FB-B32D-EC881C955B36Q38791742-727D6387-33E8-41CE-B597-F163AF339EA0Q38810784-832BECF5-1935-4567-8BFD-93C098F0ECE0Q39960078-AA91E5ED-2CE3-4C31-BC31-50D501CF3157Q41263195-691D44A9-C2BD-451A-B10F-C55D7F0F59D7Q41810665-FC558B12-CB9D-4AB2-A967-C9AF92DC9269Q51602950-5D461F6E-A520-4015-A0B0-0EFEF0B9AC01Q51689889-66B9BF7A-646D-41EC-84A9-F1AEA6EA62DDQ58572662-E3CCE6CF-70DF-4C87-AEA4-D92CFC15B4FC
P2860
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhaled corticosteroid and lon ...... ve asthma therapy in practice.
@en
type
label
Inhaled corticosteroid and lon ...... ve asthma therapy in practice.
@en
prefLabel
Inhaled corticosteroid and lon ...... ve asthma therapy in practice.
@en
P2093
P921
P1433
P1476
Inhaled corticosteroid and lon ...... ve asthma therapy in practice.
@en
P2093
Bianca Beghé
David H Richards
Michael Tamm
P356
10.1016/S0954-6111(12)70005-7
P478
106 Suppl 1
P577
2012-12-01T00:00:00Z